中文版 | English

在结果中检索

HFCAS OpenIR

浏览/检索结果: 共2条，第1-2条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Disease progression patterns and molecular resistance mechanisms to crizotinib of lung adenocarcinoma harboring ROS1 rearrangements 期刊论文
NPJ PRECISION ONCOLOGY, 2022, 卷号: 6
作者:  Zhang, Yongchang;  Huang, Zhe;  Zeng, Liang;  Zhang, Xiangyu;  Li, Yizhi;  Xu, Qinqin;  Yang, Haiyan;  Lizaso, Analyn;  Xu, Chunwei;  Liu, Jun;  Wang, Wenxian;  Song, Zhengbo;  Ou, Sai-Hong Ignatius;  Yang, Nong
收藏  |  浏览/下载：45/0  |  提交时间：2022/05/05
Anlotinib combined with PD-1 blockade for the treatment of lung cancer: a real-world retrospective study in China 期刊论文
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021
作者:  Zhang, Xiangyu;  Zeng, Liang;  Li, Yizhi;  Xu, Qinqin;  Yang, Haiyan;  Lizaso, Analyn;  Mao, Xinru;  Jin, Ren'an;  Zeng, Yu;  Li, Qinglin;  Wang, Jianbo;  Li, Yang;  Zhang, Yongchang;  Yang, Nong
收藏  |  浏览/下载：43/0  |  提交时间：2021/03/15
Anlotinib  Immunotherapy  Programmed death 1 inhibitor  Lung cancer